Saltar al contenido
Merck
Todas las fotos(1)

Documentos

1379401

USP

Meloxicam

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C14H13N3O4S2
Número de CAS:
71125-38-7
Peso molecular:
351.40
Código UNSPSC:
41116107
NACRES:
NA.24

grado

pharmaceutical primary standard

familia API

meloxicam

fabricante / nombre comercial

USP

aplicaciones

pharmaceutical (small molecule)

formato

neat

InChI

1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+

Clave InChI

DWMREKMVXIFPFM-ACCUITESSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Meloxicam USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Meloxicam Oral Suspension
  • Meloxicam Tablets

Nota de análisis

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Otras notas

Sales restrictions may apply.

Producto relacionado

Referencia del producto
Descripción
Precios

1379423

Meloxicam Related Compound B, United States Pharmacopeia (USP) Reference Standard

1379412

Meloxicam Related Compound A, United States Pharmacopeia (USP) Reference Standard

1379445

Meloxicam Related Compound D, United States Pharmacopeia (USP) Reference Standard

1379434

Meloxicam Related Compound C, United States Pharmacopeia (USP) Reference Standard

Y0001037

Meloxicam impurity C, European Pharmacopoeia (EP) Reference Standard

Y0001036

Meloxicam impurity B, European Pharmacopoeia (EP) Reference Standard

Y0001035

Meloxicam impurity A, European Pharmacopoeia (EP) Reference Standard

Y0001080

Meloxicam, European Pharmacopoeia (EP) Reference Standard

Y0001039

Meloxicam impurity D, European Pharmacopoeia (EP) Reference Standard

1379456

(Z)-N′-Methylmeloxicam, United States Pharmacopeia (USP) Reference Standard

BP629

Meloxicam, British Pharmacopoeia (BP) Reference Standard

PHR2501

Meloxicam Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2131

Meloxicam Impurity D

PHR2327

Meloxicam Impurity C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2500

Meloxicam Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2502

Meloxicam Related Compound C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2503

Meloxicam Impurity E, Pharmaceutical Secondary Standard; Certified Reference Material

Pictogramas

Skull and crossbones
GHS06

Palabra de señalización

Danger

Frases de peligro

H301

Clasificaciones de peligro

Acute Tox. 3 Oral

Código de clase de almacenamiento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Clase de riesgo para el agua (WGK)

WGK 2

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

[Efficacy and intolerance of meloxicam in injection and tablet form].
V P Tiurin et al.
Voenno-meditsinskii zhurnal, 324(11), 54-58 (2004-01-17)
[Pharma-Clinics. The drug of the month. Meloxicam (Mobic)].
A J Scheen
Revue medicale de Liege, 52(4), 309-311 (1997-04-01)
Roy Fleischmann et al.
Expert opinion on pharmacotherapy, 3(10), 1501-1512 (2002-10-22)
Meloxicam (Mobic trade mark, Boehringer Ingelheim) is a relatively new oral non-steroidal anti-inflammatory drug (NSAID) approved for the treatment of osteoarthritis in the US. It has also been evaluated for the treatment of rheumatoid arthritis, ankylosing spondylitis and acute 'rheumatic'
R Andrew Moore et al.
The Cochrane database of systematic reviews, (4)(4), CD007552-CD007552 (2009-10-13)
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) used mainly in treating pain associated with arthritis. The usual oral dose for osteoarthritis is 15 mg daily, but lower doses of 7.5 mg are advised in older patients. This review sought to
Keiko Ogino et al.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 120(6), 391-397 (2003-01-17)
Meloxicam (Mobic) is a new nonsteroidal anti-inflammatory drug (NSAID) derived from enolic acid, exhibiting selectivity for cyclooxygenase (COX)-2 over COX-1. Meloxicam has shown potent anti-inflammatory and analgesic activity together with low gastrointestinal toxicity in animal models. It is a potent
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico